| ROSS n = 20 | MIRA n = 20 | PRIMA PLUS n = 20 | MIRA n = 20 | PRIMA PLUS n = 20 | PERI- MOUNT n = 20 |
---|---|---|---|---|---|---|
Female | 8 | 9 | 11 | 10 | 9 | 12 |
Male | 12 | 11 | 9 | 10 | 11 | 8 |
Age (years) | 49 ± 8.3 | 48 ± 6.9 | 60 ± 4.1 | 62 ± 2.3 | 78 ± 3.8 | 79 ± 4.3 |
BSA (m2) | 1.82 ± 0.7 | 1.89 ± 0.4 | 1.76 ± 0.2 | 1.67 ± 0.2 | 1.79 ± 0.6 | 1.85 ± 0.8 |
Hypertension | 7 | 6 | 9 | 8 | 10 | 9 |
Atrial fibrillation | 0 | 1 | 0 | 0 | 0 | 1 |
Mean gradient (mmHg) | 56.6 ± 12.6 | 59.4 ± 16.2 | 49.0 ± 20.0 | 52.0 ± 18.0 | 58.1 ± 18.2 | 50.9 ± 14.8 |
IVS (cm) | 1.98 ± 0.2 | 1.82 ± 0.4 | 1.95 ± 0.3 | 1.97 ± 0.2 | 1.94 ± 1.9 | 1.91 ± 0.9 |
LVW (cm) | 1.95 ± 0.3 | 1.81 ± 0.2 | 1.99 ± 0.5 | 2.01 ± 0.4 | 1.93 ± 0.3 | 1.98 ± 0.2 |
LVEDD (cm) | 4.9 ± 0.5 | 4.7 ± 0.3 | 4.6 ± 0.3 | 4.8 ± 0.3 | 4.8 ± 0.4 | 4.6 ± 0.3 |
LVESD (cm) | 3.7 ± 0.4 | 3.4 ± 0.3 | 3.6 ± 0.2 | 3.9 ± 0.4 | 3.2 ± 0.3 | 3.5 ± 0.2 |
PEF EF (%) | 66.3 ± 7.9 | 67.2 ± 6.8 | 62.0 ± 7.0 | 65.0 ± 6.0 | 65.9 ± 7.4 | 66.6 ± 8.6 |
NYHA III-IV | 16 | 16 | 17 | 15 | 17 | 18 |
Concomitant CABG | 0 | 2 | 0 | 0 | 2 | 3 |